Biotech stocks poised for a major boom in 2024, according to top analysts. With FDA approval potentially pushing one biotech stock's value over $100 billion, the sector is heating up. Recent deals indicate a wave of biotech activity, and experts predict this trend will continue. The future of biotech looks bright, with vast potential for growth and innovation.